The Verdict: Interesting but inconclusive
2025, doi: 10.1016/j.ajcnut.2025.04.023
Integrin beta 1 (ITG1), a critical cell surface protein, is actively expressed in the presence of GHK and thus may serve as a primary target for its anti-fibrotic effect [14]
Acetyl-L-Carnitine and restoring missing periods Dr
Who It Is For First-time peptide therapy patients looking for a proven, well-tolerated starting point Adults over 35 experiencing declining energy, poor sleep, slower recovery, or gradual body composition changes Patients who want to optimize growth hormone naturally without exogenous GH Athletes seeking improved recovery and training adaptation Anyone building a foundation before adding more targeted peptides What to Expect Weeks 1-2: Improved sleep quality is typically the first noticeable change
Real-world persistence across GLP-1s continues to be a challenge, with tolerability consistently cited as the primary reason patients stop treatment